PLoS ONE (Jan 2021)

Mild anemia and 11- to 15-year mortality risk in young-old and old-old: Results from two population-based cohort studies

  • Alessia A. Galbussera,
  • Sara Mandelli,
  • Stefano Rosso,
  • Roberto Zanetti,
  • Marianna Rossi,
  • Adriano Giacomin,
  • Paolo Detoma,
  • Emma Riva,
  • Mauro Tettamanti,
  • Matteo G. Della Porta,
  • Ugo Lucca

Journal volume & issue
Vol. 16, no. 12

Abstract

Read online

Background Mild anemia is a frequent although often overlooked finding in old age. Nevertheless, in recent years anemia has been linked to several adverse outcomes in the elderly population. Objective of the study was to investigate the association of mild anemia (hemoglobin concentrations: 10.0–11.9/12.9 g/dL in women/men) with all-cause mortality over 11–15 years and the effect of change in anemia status on mortality in young-old (65–84 years) and old-old (80+ years). Methods The Health and Anemia and Monzino 80-plus are two door-to-door, prospective population-based studies that included residents aged 65-plus years in Biella municipality and 80-plus years in Varese province, Italy. No exclusion criteria were used. Results Among 4,494 young-old and 1,842 old-old, mortality risk over 15/11 years was significantly higher in individuals with mild anemia compared with those without (young-old: fully-adjusted HR: 1.35, 95%CI, 1.15–1.58; old-old: fully-adjusted HR: 1.28, 95%CI, 1.14–1.44). Results were similar in the disease-free subpopulation (age, sex, education, smoking history, and alcohol consumption adjusted HR: 1.54, 95%CI, 1.02–2.34). Both age groups showed a dose-response relationship between anemia severity and mortality (P for trend Conclusions Findings from these two large prospective population-based studies consistently suggest an independent, long-term impact of mild anemia on survival at older ages.